Matches in SemOpenAlex for { <https://semopenalex.org/work/W3130082008> ?p ?o ?g. }
- W3130082008 endingPage "792" @default.
- W3130082008 startingPage "792" @default.
- W3130082008 abstract "The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. A retrospective series of 357 patients with ASTS treated with trabectedin as second- or further-line in 19 centers across Spain was analyzed. First, it was confirmed that patients with high growth modulation index (GMI > 1.33) were associated with the better clinical outcome. Univariate and multivariate analyses were performed to identify factors associated with a GMI > 1.33. Thus, GEISTRA score was based on metastasis free-interval (MFI ≤ 9.7 months), Karnofsky < 80%, Non L-sarcomas and better response in the previous systemic line. The median GMI was 0.82 (0–69), with 198 patients (55%) with a GMI < 1, 41 (11.5%) with a GMI 1–1.33 and 118 (33.1%) with a GMI > 1.33. The lowest GEISTRA score showed a median of time-to-progression (TTP) and overall survival (OS) of 5.7 and 19.5 months, respectively, whereas it was 1.8 and 3.1 months for TTP and OS, respectively, for the GEISTRA 4 score. This prognostic tool can contribute to better selecting candidates for trabectedin treatment in ASTS." @default.
- W3130082008 created "2021-03-01" @default.
- W3130082008 creator A5006074198 @default.
- W3130082008 creator A5006381832 @default.
- W3130082008 creator A5006616764 @default.
- W3130082008 creator A5009957675 @default.
- W3130082008 creator A5020148113 @default.
- W3130082008 creator A5020381519 @default.
- W3130082008 creator A5021165753 @default.
- W3130082008 creator A5023000031 @default.
- W3130082008 creator A5023576532 @default.
- W3130082008 creator A5040105917 @default.
- W3130082008 creator A5046083398 @default.
- W3130082008 creator A5048077362 @default.
- W3130082008 creator A5049870523 @default.
- W3130082008 creator A5054954127 @default.
- W3130082008 creator A5056429138 @default.
- W3130082008 creator A5074487491 @default.
- W3130082008 creator A5075323885 @default.
- W3130082008 creator A5077016336 @default.
- W3130082008 creator A5082196593 @default.
- W3130082008 creator A5083287208 @default.
- W3130082008 creator A5090906445 @default.
- W3130082008 date "2021-02-14" @default.
- W3130082008 modified "2023-10-15" @default.
- W3130082008 title "A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study" @default.
- W3130082008 cites W1502294265 @default.
- W3130082008 cites W1884818927 @default.
- W3130082008 cites W1955072209 @default.
- W3130082008 cites W2004724104 @default.
- W3130082008 cites W2009175936 @default.
- W3130082008 cites W2019607817 @default.
- W3130082008 cites W2057195209 @default.
- W3130082008 cites W2069308265 @default.
- W3130082008 cites W2077514628 @default.
- W3130082008 cites W2087755372 @default.
- W3130082008 cites W2090073404 @default.
- W3130082008 cites W2096279999 @default.
- W3130082008 cites W2098363392 @default.
- W3130082008 cites W2107078868 @default.
- W3130082008 cites W2108003570 @default.
- W3130082008 cites W2113855026 @default.
- W3130082008 cites W2117431699 @default.
- W3130082008 cites W2120685711 @default.
- W3130082008 cites W2131786551 @default.
- W3130082008 cites W2136344041 @default.
- W3130082008 cites W2167367924 @default.
- W3130082008 cites W2168598691 @default.
- W3130082008 cites W2222799915 @default.
- W3130082008 cites W2397619801 @default.
- W3130082008 cites W2520149112 @default.
- W3130082008 cites W2588887079 @default.
- W3130082008 cites W2757281125 @default.
- W3130082008 cites W2763546606 @default.
- W3130082008 cites W2790645241 @default.
- W3130082008 cites W2889988520 @default.
- W3130082008 cites W2924965540 @default.
- W3130082008 cites W2943107541 @default.
- W3130082008 cites W2994811269 @default.
- W3130082008 cites W3013604427 @default.
- W3130082008 doi "https://doi.org/10.3390/cancers13040792" @default.
- W3130082008 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7917652" @default.
- W3130082008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33672857" @default.
- W3130082008 hasPublicationYear "2021" @default.
- W3130082008 type Work @default.
- W3130082008 sameAs 3130082008 @default.
- W3130082008 citedByCount "6" @default.
- W3130082008 countsByYear W31300820082021 @default.
- W3130082008 countsByYear W31300820082022 @default.
- W3130082008 countsByYear W31300820082023 @default.
- W3130082008 crossrefType "journal-article" @default.
- W3130082008 hasAuthorship W3130082008A5006074198 @default.
- W3130082008 hasAuthorship W3130082008A5006381832 @default.
- W3130082008 hasAuthorship W3130082008A5006616764 @default.
- W3130082008 hasAuthorship W3130082008A5009957675 @default.
- W3130082008 hasAuthorship W3130082008A5020148113 @default.
- W3130082008 hasAuthorship W3130082008A5020381519 @default.
- W3130082008 hasAuthorship W3130082008A5021165753 @default.
- W3130082008 hasAuthorship W3130082008A5023000031 @default.
- W3130082008 hasAuthorship W3130082008A5023576532 @default.
- W3130082008 hasAuthorship W3130082008A5040105917 @default.
- W3130082008 hasAuthorship W3130082008A5046083398 @default.
- W3130082008 hasAuthorship W3130082008A5048077362 @default.
- W3130082008 hasAuthorship W3130082008A5049870523 @default.
- W3130082008 hasAuthorship W3130082008A5054954127 @default.
- W3130082008 hasAuthorship W3130082008A5056429138 @default.
- W3130082008 hasAuthorship W3130082008A5074487491 @default.
- W3130082008 hasAuthorship W3130082008A5075323885 @default.
- W3130082008 hasAuthorship W3130082008A5077016336 @default.
- W3130082008 hasAuthorship W3130082008A5082196593 @default.
- W3130082008 hasAuthorship W3130082008A5083287208 @default.
- W3130082008 hasAuthorship W3130082008A5090906445 @default.
- W3130082008 hasBestOaLocation W31300820081 @default.
- W3130082008 hasConcept C126322002 @default.
- W3130082008 hasConcept C136948725 @default.
- W3130082008 hasConcept C141071460 @default.
- W3130082008 hasConcept C142724271 @default.
- W3130082008 hasConcept C143998085 @default.